Pharma Giants Eye US Market Growth with Complex Generics by 2025

Indian pharmaceutical firms, having gained from favorable sector trends like steady generic pricing and opportunities arising from shortages, alongside stable raw material costs over the last 18-24 months, are expected to advance further in...

Afrezza Revolutionizes Diabetes Care with Inhalable Insulin

Afrezza is the first and sole noninjection insulin created for individuals with both type 1 and type 2 diabetes mellitus. Afrezza, created and produced by MannKind Corporation (MannKind) in the USA, is intended to enhance glycemic control in adult...

Counterfeit Drug Detection Market to Grow 3.3% CAGR

The expansion of the global counterfeit drug detection device market is propelled by a compounded annual growth rate (CAGR) of 3.3% in the upcoming ten years, indicating an increased international emphasis on addressing the rising issue of fake...

Pharma FDI Surges After 48% Dip Last Year

The Foreign Direct Investment (FDI) equity into the pharmaceutical industry has shown significant growth in the first half of 2024-25, following a 48 percent drop in fiscal 2023-24 compared to the prior year. The quarter from April to September of...

Pharma Packaging Market Grows with Innovation and Sustainability Focus

The global pharmaceutical packaging market is consistently expanding due to the demand for more innovative packaging that improves drug effectiveness while integrating sustainable packaging solutions. The Global Pharmaceutical Packaging Market is...

Pharma Market Up 9.9% in Value, 3.1% in Volume for November

The Indian pharmaceutical market (IPM) saw an increase of 9.9% in value and 3.1% in volume in November, as per Pharmarack. Following a lackluster volume growth for four months, November emerged as a favorable month for the sector, suggesting an...

Indian Pharma Soars 9.9%, Powered by Pricing and New Launches

The Indian pharmaceutical market showed a growth of 9.9% year-on-year in November 2024, compared to an average growth of 6.0% year-on-year during the July-October period (which was up 2.9% YoY in November 2023). The overall increase during the...

Obesity Market Boom Propels Major Pharma firms to Global Top-Tier Status

The rising global demand for weight-loss drugs has propelled major pharmaceuticals firms Eli lilly and Novo Nordisk among the world's most valuable companies as they aggressively compete in the obesity market that analysts predict could cross $100...

India's Indigenous Antibiotic to Combat AMR Highlights Pharma Progress

The arrival of nafithromycin, the nation’s initial homegrown macrolide antibiotic currently waiting for final endorsement from the Central Drugs Standard Control Organization (CDSCO), will mark a crucial moment in the battle against antimicrobial...

Generic Pharma Booms as Demand Fuels Growth and Innovation

The market for generic pharmaceuticals is experiencing notable expansion driven by the rising demand for affordable medications and advancements in drug production. Most generic medications fall under the category of prescription drugs. According...